Advanced search
Publication Cover
Clinical Ophthalmology Volume 17, 2023 - Issue
Submit an article Journal homepage
85
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Vitreoretinal Specialist Use of Ancillary Testing: An IRIS® Registry Analysis

Saloni Vishwakarma1 Quantitative Sciences Department, Verana Health, San Francisco, CA, USAView further author information
,
Durga S Borkar2 Ophthalmology Department, Duke University Eye Center, Duke University School of Medicine, Durham, NC, USAView further author information
,
Andrew LaPrise1 Quantitative Sciences Department, Verana Health, San Francisco, CA, USAView further author information
,
Michael Mbagwu1 Quantitative Sciences Department, Verana Health, San Francisco, CA, USAView further author information
&
Theodore Leng3 Ophthalmology Department, Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8461-3562View further author information
ORCID Icon
Pages 3077-3085 | Received 01 Aug 2023, Accepted 11 Oct 2023, Published online: 18 Oct 2023

References

  • Swanson EA, Izatt JA, Hee MR, et al. In vivo retinal imaging by optical coherence tomography. Opt Lett. 1993;18(21):1864–1866. doi:10.1364/OL.18.001864
  • Schneider EW, Mruthyunjaya P, Talwar N, Harris Nwanyanwu K, Nan B, Stein JD. Reduced fluorescein angiography and fundus photography use in the management of neovascular macular degeneration and macular edema during the past decade. Invest Ophthalmol Vis Sci. 2014;55(1):542–549. doi:10.1167/iovs.13-13034
  • Wibbelsman TD, Pandit RR, Xu D, et al. Trends in Retina Specialist Imaging Utilization from 2012 to 2016 in the United States Medicare Fee-for-Service Population. Am J Ophthalmol. 2019;208:12–18. doi:10.1016/j.ajo.2019.06.026
  • Pontikos N, Wagner SK, Balaskas K, et al. Comment on: trends in Retina Specialist Imaging Utilization From 2012 to 2016 in the United States Medicare Fee-for-Service Population. Am J Ophthalmol. 2020;211:229. doi:10.1016/j.ajo.2019.09.021
  • American Academy of Ophthalmology (Academy). Retinal Vein Occlusions Preferred Practice Pattern. Elsevier Inc; 2019.
  • American Academy of Ophthalmology (Academy). Age-Related Macular Degeneration Preferred Practice Pattern. Elsevier Inc; 2019.
  • American Academy of Ophthalmology (Academy). Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern. Elsevier Inc; 2019.
  • American Academy of Ophthalmology (Academy). Diabetic Retinopathy Preferred Practice Pattern. Elsevier Inc; 2019.
  • Ho AC, Wibbelsman TD, Pandit RR, Xu D. Trends in Ophthalmic Imaging: implications and Outlook. Am J Ophthalmol. 2020;210:1–2. doi:10.1016/j.ajo.2019.10.008
  • American Academy of Ophthalmology (Academy). IRIS Registry. Available from: https://www.aao.org/iris-registry. Accessed October 12, 2023.
  • Parikh R, Ross JS, Sangaralingham LR, Adelman RA, Shah ND, Barkmeier AJ. Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients. Ophthal. 2017;124(3):352–358. doi:10.1016/j.ophtha.2016.10.036
  • Gragoudas ES, Adamis AP, Cunningham ET, Feinsod M, Guyer DR; Group VISiONCT. Pegaptanib for neovascular age-related macular degeneration. New Engl J Med. 2004;351(27):2805–2816. doi:10.1056/NEJMoa042760
  • Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419–1431. doi:10.1056/NEJMoa054481
  • Khanna S, Komati R, Eichenbaum DA, Hariprasad I, Ciulla TA, Hariprasad SM. Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review. BMJ Open Ophthalmol. 2019;4(1):e000398. doi:10.1136/bmjophth-2019-000398
  • Rein DB, Wittenborn JS, Burke-Conte Z, et al. Prevalence of Age-Related Macular Degeneration in the US in 2019. JAMA Ophthalmol. 2022;140(12):1202–1208. doi:10.1001/jamaophthalmol.2022.4401
  • Pron G. Optical Coherence Tomography Monitoring Strategies for A-VEGF-Treated Age-Related Macular Degeneration: an Evidence-Based Analysis. Ont Health Technol Assess Ser. 2014;14(10):1–64.
  • Windsor MA, Sun SJJ, Frick KD, Swanson EA, Rosenfeld PJ, Huang D. Estimating Public and Patient Savings From Basic Research-A Study of Optical Coherence Tomography in Managing Antiangiogenic Therapy. Am J Ophthalmol. 2018;185:115–122. doi:10.1016/j.ajo.2017.09.027
  • Bureau USC. 2020 United States Census; 2019

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.